AUSTAR (06118) FY22 profit RMB87.46M, down 68% X
29/03/2023 11:26
(Infocast News)      Results of Austar Lifesciences Limited (06118) for the fiscal year ended 31 December 2022:

Net profit: RMB87.461M, down 68.46% YoY (RMB277.3M net profit for the same period last year) 
Basic EPS: RMB0.17
Dividend per share proposed: (Nil)

(WH)



Infocast Limited and its information providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.